FDA & THC Disclaimer

FDA Disclaimer

Regulatory Status

VAZPE products are electronic nicotine delivery systems (ENDS) and are subject to various regulatory frameworks depending on your location. In the United States, these products fall under FDA oversight as tobacco products.

FDA Tobacco Product Regulations (US)

• VAZPE products are intended for adult use only (21+ in the US – federal requirement since December 2019)
• Products are not approved by the FDA as smoking cessation aids or medical devices
• We comply with applicable FDA regulations for deemed tobacco products under Section 201(rr) of the Federal Food, Drug, and Cosmetic Act
• All advertising and marketing claims comply with FDA guidelines and restrictions on youth appeal
• Products are manufactured following current good manufacturing practices where applicable
• Age verification required for all online sales as mandated by federal law
• Adult signature required upon delivery as per FDA regulations

Health Claims Disclaimer

VAZPE does not make any claims that our products:

• Are safe or safer than traditional cigarettes
• Will help you quit smoking
• Have any therapeutic or medicinal benefits
• Are free from health risks
• Are approved by any health authority for medical use

THC & Cannabis Disclaimer

Cannabis Regulations Compliance

While cannabis laws vary by jurisdiction, VAZPE maintains a clear position:

• No THC, CBD, or other cannabinoids in any VAZPE products
• No cannabis-derived terpenes or extracts
• All ingredients are legally sourced and FDA-approved for use
• Products comply with international shipping regulations
• No association with cannabis or marijuana industry

Testing & Verification

VAZPE products undergo regular third-party testing to verify:

• Absence of THC and other controlled substances
• Accurate nicotine content labeling
• Purity of ingredients
• Absence of harmful contaminants
• Compliance with applicable regulations

Health Warnings

Nicotine Health Information

Nicotine-containing products carry inherent health risks that users should understand:

• Addiction: Nicotine is highly addictive and can lead to dependence
• Cardiovascular Effects: May increase heart rate and blood pressure
• Pregnancy Risks: Harmful to developing fetuses and infants
• Youth Risk: Particularly harmful to developing brains in adolescents
• Medical Conditions: May exacerbate certain health conditions

Contraindications

VAZPE products should not be used by:

• Individuals under the legal age (18+ or 21+ depending on jurisdiction)
• Pregnant or nursing women
• Individuals with heart conditions or high blood pressure
• People with respiratory conditions
• Those allergic to nicotine or other ingredients
• Individuals taking medication for depression or asthma
• Non-smokers or those who have never used nicotine products

International Regulatory Compliance

Multi-Jurisdictional Compliance

VAZPE operates internationally and complies with various regulatory frameworks. Important: Regulations are changing rapidly in 2024-2025, with many countries implementing stricter controls.

Regulatory Changes

The regulatory landscape for vaping products continues to evolve. VAZPE monitors regulatory changes and updates our compliance practices accordingly. Customers are responsible for ensuring products are legal in their jurisdiction.

Product Safety Information

Safe Usage Guidelines

To ensure safe use of VAZPE products:

• Read Instructions: Always read and follow all product instructions
• Proper Storage: Store products away from children and pets
• Temperature Control: Avoid extreme temperatures
• Battery Safety: Use only recommended chargers and batteries
• Regular Maintenance: Clean and maintain devices according to instructions
• Discontinue if Issues: Stop use if you experience any adverse effects

Emergency Information

Allergic Reactions

If you experience any of the following symptoms, discontinue use immediately and consult a healthcare provider:

• Difficulty breathing or wheezing
• Skin rash, itching, or hives
• Swelling of face, lips, tongue, or throat
• Severe dizziness or lightheadedness
• Rapid or irregular heartbeat
• Nausea, vomiting, or severe headache

Ingredient Disclosure

Common Ingredients

VAZPE products typically contain the following FDA-approved ingredients:

• Nicotine: Naturally derived or synthetic nicotine
• Propylene Glycol (PG): Aditivo alimentar e transportador aprovados pela FDA
• Vegetable Glycerin (VG): Plant-derived, FDA-approved sweetener
• Flavorings: Aromatizantes de qualidade alimentar aprovados pela FDA
• Other Additives: May include preservatives or stabilizers as approved

Ingredients We Don’t Use

VAZPE products do not contain:

• THC, CBD, or other cannabinoids
• Tobacco leaf or tobacco-derived materials (except nicotine)
• Vitamin E acetate
• Diacetyl or acetyl propionyl
• Heavy metals above regulatory limits
• Formaldehyde or other known carcinogens as primary ingredients

Research & Studies

Current Research Status

The long-term health effects of vaping and e-cigarette use are still being studied by the scientific community. While some studies suggest reduced harm compared to traditional cigarettes, comprehensive long-term data is still emerging.

Independent Studies

VAZPE does not conduct or fund independent health studies on vaping products. We rely on peer-reviewed scientific research and regulatory guidance from health authorities for product safety information.

Ongoing Monitoring

We continuously monitor:

• New scientific research on vaping and health
• Regulatory updates from health authorities
• Industry safety developments and best practices
• Customer feedback and adverse event reports

Legal Disclaimers

Limitation of Liability

By using VAZPE products, you acknowledge and agree that:

• Use of nicotine products carries inherent risks
• VAZPE is not liable for health effects from product use
• You assume responsibility for compliance with local laws
• You use products at your own risk
• You have read and understood all warnings and disclaimers

Medical Advice Disclaimer

Jurisdiction-Specific Laws

Users are responsible for ensuring VAZPE products are legal in their jurisdiction. Some areas may have restrictions or prohibitions on:

• Purchase or possession of vaping products
• Use in public places
• Import or transport across borders
• Age restrictions beyond our stated minimums
• Licensing or registration requirements

Reporting Adverse Events

How to Report

If you experience any adverse effects from VAZPE products, please report them to:

• VAZPE Customer Service: [email protected]
• FDA (US): FDA Safety Reporting Portal or 1-800-FDA-1088
• Health Canada: Canada Vigilance Program
• EU: National competent authorities
• Your Healthcare Provider: Always consult your doctor

Information to Include

When reporting adverse events, please include:

• Product name and batch/lot number
• Date of purchase and first use
• Description of adverse event
• Timeline of symptoms
• Your contact information
• Healthcare provider information if applicable

Updates to This Disclaimer

This disclaimer may be updated periodically to reflect:

• New regulatory requirements
• Updated scientific information
• Changes in product formulations
• Legal developments
• Industry best practices

Updates will be posted on our website with the revised date. Continued use of VAZPE products after updates constitutes acceptance of the revised disclaimer.